DOI QR코드

DOI QR Code

Breast Cancer Trend in Iran from 2000 to 2009 and Prediction till 2020 using a Trend Analysis Method

  • Zahmatkesh, Bibihajar (Pathology Department, School of Nursing and Midwifery, Shahroud University of Medical Sciences) ;
  • Keramat, Afsaneh (School of Nursing and Midwifery, Shahroud University of Medical Sciences) ;
  • Alavi, Nasrinossadat (Breast Cancer Research Center, ACECR) ;
  • Khosravi, Ahmad (Pathology Department, Center for Health Related Social and Behavioral Sciences Research, Shahroud University of Medical Sciences) ;
  • Kousha, Ahmad (Faculty of Health Tabriz University of Medical Sciences) ;
  • Motlagh, Ali Ghanbari (Radiation Oncology, Shahid Beheshti University of Medical Sciences) ;
  • Darman, Mahboobeh (Expert At Noncomunicable Disease Center) ;
  • Partovipour, Elham (MS, Non-Communicable diseases, Deputy of Health, Ministry of Health and Medical Education) ;
  • Chaman, Reza (Department of Community Medicine, School of Medicine, Yasuj University of Medical Sciences)
  • Published : 2016.04.11

Abstract

Background: Breast cancer is the most common cancer in women worldwide with a rising incidence rate in most countries. Considering the increase in life expectancy and change in lifestyle of Iranian women, this study investigated the age-adjusted trend of breast cancer incidence during 2000-2009 and predicted its incidence to 2020. Materials and Methods: The 1997 and 2006 census results were used for the projection of female population by age through the cohort-component method over the studied years. Data from the Iranian cancer registration system were used to calculate the annual incidence rate of breast cancer. The age-adjusted incidence rate was then calculated using the WHO standard population distribution. The five-year-age-specific incidence rates were also obtained for each year and future incidence was determined using the trend analysis method. Annual percentage change (APC) was calculated through the joinpoint regression method. Results: The bias adjusted incidence rate of breast cancer increased from 16.7 per 100,000 women in 2000 to 33.6 per 100,000 women in 2009. The incidence of breast cancer had a growing trend in almost all age groups above 30 years over the studied years. In this period, the age groups of 45-65 years had the highest incidence. Investigation into the joinpoint curve showed that the curve had a steep slope with an APC of 23.4% before the first joinpoint, but became milder after this. From 2005 to 2009, the APC was calculated as 2.7%, through which the incidence of breast cancer in 2020 was predicted as 63.0 per 100,000 women. Conclusions: The age-adjusted incidence rate of breast cancer continues to increas in Iranian women. It is predicted that this trend will continue until 2020. Therefore, it seems necessary to prioritize the prevention, control and care for breast cancer in Iran.

Keywords

References

  1. AL-Hashimi MMY, Wang XJ (2014). Breast cancer in Iraq, incidence trends from 2000-2009. Asian Pac J Cancer Prev, 15, 281-6. https://doi.org/10.7314/APJCP.2014.15.1.281
  2. American cancer society (2013). Breast cancer facts and figures 2013-2014 [Online]. Atlanta: American Cancer Society.
  3. American Cancer Society (2015). Cancer Facts and Figures 2015 [Online].
  4. Asadzadeh Vostakolaei F, Broeders MJM, Mousavi SM, et al (2013). The effect of demographic and lifestyle changes on the burden of breast cancer in Iranian women: A projection to 2030. Breast, 22, 277-81. https://doi.org/10.1016/j.breast.2012.07.002
  5. Beiki O, Hall P, Ekbom A, et al (2012). Breast cancer incidence and case fatality among 4.7 million women in relation to social and ethnic background: a population-based cohort study. Breast Cancer Res, 14, 5.
  6. Benson JR, Jatoi I (2012). The global breast cancer burden. Future Oncol, 8, 697-702. https://doi.org/10.2217/fon.12.61
  7. Bhurgri Y, Kayani N, Faridi N, et al (2007). Patho-epidemiology of Breast Cancer in Karachi1995-1997'. Asian Pac J Cancer Prev, 8, 215-20.
  8. Boyle P, A. H (2010). The globalisation of breast cancer. Breast Cancer Res Crops, 12, 7.
  9. Center for Disease Control and Prevention NDCO (2010). Country reports cancer registration 2008. Iran. 8-17.
  10. Center for Disease Control and Prevention NDCO (2012). Country reports cancer registration 2009. Iran. 12-3.
  11. Chlebowski RT, Kuller LH, Prentice RL, et al (2009). Breast cancer after use of estrogen plus progestin in postmenopausal women. New England J Med, 360, 573-87. https://doi.org/10.1056/NEJMoa0807684
  12. Daubisse-Marliac L, Delafosse P, Boitard JB, et al (2011). Breast cancer incidence and time trend in France from 1990 to 2007: a population-based study from two French cancer registries. Ann Oncol, 22, 329-34. https://doi.org/10.1093/annonc/mdq396
  13. Enayatrad M, Salehiniya H (2015). An investigation of changing patterns in breast cancer incidence trends among Iranian women. Quarterly J Sabzevar Uni Med Sci, 22, 27-35.
  14. Fateh M, Emamian MH (2013). Cancer incidence and trend analysis in Shahroud, Iran, 2000 - 2010. Iran J Cancer Prev, 6, 85-94.
  15. Ferlay J, Soerjomataram I, Dikshit R, et al (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136, 359-86. https://doi.org/10.1002/ijc.29210
  16. Hosseini MS, Arab M, Honar BN, et al (2013). Age - specific incidence rate change at breast cancer and its different histopathologic subtypes in Iran and Western countries. Pak J Med Sci, 29, 1354-7.
  17. IARC. 2012. GLOBOCAN 2012: Estimated age-standardised incidence and mortality rates. Fact Sheets. Population Fact Sheets: women [Online].
  18. Jafari-Koshki T, Schmid VJ, Mahaki B (2014). Trends of breast cancer incidence in Iran During 2004-2008: A Bayesian space-time model. Asian Pac J Cancer Prev, 15, 1557-61. https://doi.org/10.7314/APJCP.2014.15.4.1557
  19. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  20. Jiang Z, Qiu Z, Hatcher J (2007). Joinpoint trend analysis of cancer incidence and mortality using alberta data. 4-9.
  21. Jung KW, Won YJ, Kong HJ, et al (2013). Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat, 45, 1-14. https://doi.org/10.4143/crt.2013.45.1.1
  22. Jung KW, Won YJ, Park S, et al (2009). Cancer statistics in Korea: incidence, mortality and survival in 2005. J Korean Med Sci, 24, 995-1003. https://doi.org/10.3346/jkms.2009.24.6.995
  23. Kiadaliri AA (2013). Social disparity in breast and ovarian cancer incidence in iran, 2003-2009: a time trend province-level study. J Breast Cancer, 16, 372-7. https://doi.org/10.4048/jbc.2013.16.4.372
  24. Kohler BA, Sherman RL, Howlader N, et al (2015). Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and State. J Natl Cancer Inst, 107, 1-25. https://doi.org/10.1093/jnci/dju353
  25. Lee JH, Yim SH, Won YJ, et al (2007). Population-based breast cancer statistics in Korea during 1993-2002: incidence, mortality, and survival. J Korean Med Sci, 22, 11-6. https://doi.org/10.3346/jkms.2007.22.S.S11
  26. Mofrad MH, Shandiz FH, Roodsare FV, et al (2010). Evaluation of ovarian cysts in breast cancer cases on tamoxifen. Asian Pac J Cancer Prev, 11, 161-4.
  27. Mousavi SM, Zheng T, Dastgiri S, et al (2009). Age distribution of breast cancer in the Middle East, implications for screening. Breast J, 15, 677-9. https://doi.org/10.1111/j.1524-4741.2009.00843.x
  28. National Cancer Registry Ireland (2006). Trends in Irish cancer incidence 1994-2002 with predictions to 2020. 5-7.
  29. Ozmen V (2008). Breast cancer in the world and Turkey. Meme Sagligi Dergisi/J Breast Health, 2-5.
  30. Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
  31. Rafiemanesh H, Rajaei-Behbahani N, Khani Y, et al (2015). Incidence Trend and Epidemiology of Common Cancers in the Center of Iran. Glob J Health Sci, 8, 146-55.
  32. Salim EI, Moore MA, Al-Lawati JA, et al (2009). Cancer epidemiology and control in the arab world-past, present and future. Asian Pac J Cancer Prev, 10, 3-16.
  33. Shin H-R, Joubert C, Boniol M, et al (2010). Recent trends and patterns in breast cancer incidence among Eastern and Southeastern Asian women. Cancer Causes and Control, 21, 1777-85. https://doi.org/10.1007/s10552-010-9604-8
  34. Shin M, Oh H, Ahn Y (2008). Ten year trend of cancer incidence in Seoul, Korea: 1993-2002. J Prev Med Public Health, 41, 92-9. https://doi.org/10.3961/jpmph.2008.41.2.92
  35. Taheri NS, Bakhshandehnosrat S, Tabiei MN, et al (2012). Epidemiological pattern of breast cancer in Iranian women: is there an ethnic disparity? Asian Pac J Cancer Prev, 13, 4517-20. https://doi.org/10.7314/APJCP.2012.13.9.4517
  36. Takiar R, Srivastav A (2008). Time trend in breast and cervix cancer of women in India - (1990-2003). Asian Pac J Cancer Prev, 9, 777-80.
  37. Tazhibi M, Fazeli Z, Babazadeh S (2014). Trends in breast cancer incidence rates by age and tumor characteristics of women in the city of Isfahan for the period 2001-2010: an application of joinpoint analysis. J Res Med Sci, 19, 319-25.
  38. Yang BH, Parkin DM, Cai L, et al (2004). Cancer burden and trends in the Asian Pacific Rim region. Ann Epidemiol, 14, 596.
  39. Yip CH, Taib N, Mohamed I (2006). Epidemiology of breast cancer in Malaysia. Asian Pac J Cancer Prev, 7, 369-74.

Cited by

  1. Role of Menopause and Early Menarche in Breast Cancer: A Meta-Analysis of Iranian Studies vol.6, pp.1, 2016, https://doi.org/10.5812/nmsjournal.37712
  2. Role of Menopause and Early Menarche in Breast Cancer: A Meta-Analysis of Iranian Studies vol.In press, pp.In press, 2016, https://doi.org/10.17795/nmsjournal37712
  3. Induces Apoptosis and Inhibits Proliferation, Invasion, and Migration of Human Breast Cancer Cells vol.33, pp.6, 2018, https://doi.org/10.1089/cbr.2017.2432